HEATHER GARRETT: Open Payments
NPI 1316144264 · KILLEN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$440 in 32 payments from 10 companies in 2025. Trend: 2023 $525 · 2024 $348 · 2025 $440
Food & beverage: $440
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $174 |
| Lilly USA, LLC | 3 | $67 |
| ABBVIE INC. | 2 | $45 |
| PFIZER INC. | 2 | $33 |
| AstraZeneca Pharmaceuticals LP | 1 | $28 |
| Phathom Pharmaceuticals, Inc. | 2 | $22 |
| Corcept Therapeutics | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Abbott Laboratories | 1 | $15 |
Products named: Wegovy, Ozempic, JARDIANCE, NURTEC ODT, FARXIGA, VRAYLAR, MOUNJARO, VOQUEZNA.
Industry payments across AL — which companies pay providers there.
